Your browser doesn't support javascript.
loading
Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria.
Sowunmi, Akintunde; Ntadom, Godwin; Akano, Kazeem; Ibironke, Folasade O; Ayede, Adejumoke I; Agomo, Chimere; Folarin, Onikepe A; Gbotosho, Grace O; Happi, Christian; Oguche, Stephen; Okafor, Henrietta U; Meremikwu, Martin; Agomo, Philip; Ogala, William; Watila, Ismaila; Mokuolu, Olugbenga; Finomo, Finomo; Ebenebe, Joy C; Jiya, Nma; Ambe, Jose; Wammanda, Robinson; Emechebe, George; Oyibo, Wellington; Useh, Francis; Aderoyeje, Temitope; Dokunmu, Titilope M; Alebiosu, Omobolaji T; Amoo, Sikiru; Basorun, Oluwabunmi K; Wewe, Olubunmi A; Okafor, Chukwuebuka; Akpoborie, Odafe; Fatunmbi, Bayo; Adewoye, Elsie O; Ezeigwe, Nnenna M; Oduola, Ayoade.
Afiliación
  • Sowunmi A; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria. akinsowunmi@hotmail.com.
  • Ntadom G; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria. akinsowunmi@hotmail.com.
  • Akano K; Institute for Medical Research and Training, University of Ibadan, Ibadan, Nigeria. akinsowunmi@hotmail.com.
  • Ibironke FO; Department of Clinical Pharmacology, University College Hospital, Ibadan, Ibadan, Nigeria. akinsowunmi@hotmail.com.
  • Ayede AI; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Agomo C; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
  • Folarin OA; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Gbotosho GO; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
  • Happi C; Department of Biological Sciences and African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer University, Ede, Nigeria.
  • Oguche S; Department of Clinical Pharmacology, University College Hospital, Ibadan, Ibadan, Nigeria.
  • Okafor HU; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria.
  • Meremikwu M; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Agomo P; Department of Medical Laboratory Science, University of Lagos, Lagos, Nigeria.
  • Ogala W; Department of Biological Sciences and African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer University, Ede, Nigeria.
  • Watila I; Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria.
  • Mokuolu O; Institute for Medical Research and Training, University of Ibadan, Ibadan, Nigeria.
  • Finomo F; Department of Pharmacology and Toxicology, University of Ibadan, Ibadan, Nigeria.
  • Ebenebe JC; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Jiya N; Department of Biological Sciences and African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer University, Ede, Nigeria.
  • Ambe J; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Wammanda R; Department of Paediatrics, University of Jos, Jos, Nigeria.
  • Emechebe G; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Oyibo W; Department of Pediatrics, Institute of Child Health, University of Nigeria Teaching Hospital, Enugu, Nigeria.
  • Useh F; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Aderoyeje T; Department of Paediatrics, University of Calabar, Calabar, Cross River State, Nigeria.
  • Dokunmu TM; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Alebiosu OT; Nigeria Institute of Medical Research, Lagos, Nigeria.
  • Amoo S; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Basorun OK; Department of Paediatrics, Ahmadu Bello University, Zaria, Nigeria.
  • Wewe OA; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Okafor C; Department of Paediatrics, Specialist Hospital, Maiduguri, Nigeria.
  • Akpoborie O; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Fatunmbi B; Department of Paediatrics and Child Health, University of Ilorin, Ilorin, Nigeria.
  • Adewoye EO; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
  • Ezeigwe NM; Department of Paediatrics, Federal Medical Centre, Yenagoa, Nigeria.
  • Oduola A; Antimalarial Therapeutic Efficacy Monitoring Group, National Malaria Elimination Programme, The Federal Ministry of Health, Abuja, Nigeria.
Infect Dis Poverty ; 8(1): 69, 2019 Aug 06.
Article en En | MEDLINE | ID: mdl-31383040
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Resistencia a Medicamentos / Malaria Falciparum / Artemisininas / Antimaláricos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Africa Idioma: En Revista: Infect Dis Poverty Año: 2019 Tipo del documento: Article País de afiliación: Nigeria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Resistencia a Medicamentos / Malaria Falciparum / Artemisininas / Antimaláricos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Africa Idioma: En Revista: Infect Dis Poverty Año: 2019 Tipo del documento: Article País de afiliación: Nigeria